- Company Information
- Key Financials (last Fiscal Year)
- Profit Ratios
- Earnings Per Share (last Fiscal Year)
- Total Return
- Updated:6/3/26
- Country/Territory:U.S.
- Headquarters:Bridgewater, N.J.
- Industry:Pharmaceuticals
- CEO:Chirag K. Patel/Chintu Patel
- Website:https://www.amneal.com
- Ticker:AMRX
- Company type:Public
- Revenues ($M):$3,019
- Profits ($M):$72
- Market value ($M):$3,965
- Number of employees:8,700
Market value as of March 31, 2026.
- $ millions% change
- Revenues ($M):$3,018.88.1%
- Profits ($M):$72.1-
- Assets ($M):$3,678.3-
- Total Stockholder Equity ($M):$-70.8-
- Profit as % of Revenues:2.4%
- Profits as % of Assets:2%
- Profits as % of Stockholder Equity:-
- Earnings Per Share ($):0.20
- EPS % Change (from prior fiscal year):-
- EPS % Change (5 year annual rate):-18.5%
- EPS % Change (10 year annual rate):-
- Total Return to Investors (last year):59.1%
- Total Return to Investors (5 year, annualized):22.5%
- Total Return to Investors (10 year, annualized):-11.5%
Amneal Pharmaceuticals stock chart
Amneal Pharmaceuticals in Fortune Rankings